The Role of Sonography in Selective Laser Photocoagulation Therapy for the Treatment of Severe Twin-to-Twin Transfusion Syndrome:
A Literature Review AMBER REAS, BS RT(R)(M), BS RVT Twin-to-twin transfusion syndrome (TTTS) is a serious complication occurring in a significant number of monochorionic twin pregnancies. Vascular anastamoses within the shared placenta lead to a potentially fatal hemodynamic imbalance from one twin to the other. Advances in sonography and endoscopic fetal surgery have led to treatment options, including selective laser photocoagulation of communicating vessels (SLPCV) and amnioreduction therapy. Recent research has allowed the development of a sonographically based staging system, which is being found useful in determining the optimal treatment method for individual cases based on the severity of TTTS by stage. This literature review aims to improve obstetrical sonographers' understanding of the role they play in the overall evaluation of patients with TTTS and to offer suggestions and available techniques, as well as provide expectations, that may aid them in their evaluation of these patients, particularly during SLPCV therapy.
Key words: amniocentesis, Doppler, laser coagulation, monochorionic twins, twin-to-twin transfusion syndrome, ultrasound, vascular anastamoses Twin-to-twin transfusion syndrome (TTTS) is a serious condition that complicates approximately 10% to 20% of monochorionic, diamniotic twin pregnancies. 1-6 TTTS is the result of the unbalanced shunting of blood from one twin (the donor) to the other twin (the recipient) through abnormal arteriovenous anastamoses within the shared placenta. The donor twin donates a hemodynamically significant amount of its blood to the recipient twin, leading to severe hypervolemia and cardiac overload in the recipient and hypovolemia, intrauterine growth restriction (IUGR), and renal failure in the donor. The syndrome is initially diagnosed sonographically based on the presence of polyhydramnios, defined as a > 8-cm maximum vertical pocket (MVP) in the sac of one twin and oligohydramnios of < 2 cm MVP in the sac of the other twin. 5 Other sonographic parameters useful in the potential diagnosis of TTTS include discordant fetal weight, single placenta, thin dividing membrane without twin peak sign, same sex, hydrops, and abnormal Doppler studies. 1-8 If left untreated, severe cases of TTTS carry an 80% to 100% risk of perinatal mortality. 1-4 A variety of treatments have been attempted for TTTS. Traditionally, the most promising has been serial amnioreduction. Over the past decade, laser photocoagulation of the vascular anastamoses has been introduced as a more cause-oriented approach to the disorder. 2, 8 Sonography has been a key component in the preoperative, operative, postoperative, and follow-up evaluation in cases of severe TTTS managed with laser photocoagulation therapy.
Laser Photocoagulation Therapy
Laser photocoagulation therapy is an attempt to cure severe TTTS by addressing the underlying cause of the syndrome: the abnormal communication of vessels on the surface of the shared placenta. The problematic anastomoses are typically located within the sac of the recipient twin. Using sonographic guidance, an endoscope is placed percutaneously into the amniotic sac of the recipient twin. The surgeon then surveys the entire placenta for superficial anastamoses between the umbilical cords of the two fetuses. In addition, deep anastamoses are detected by noting areas in the placenta where the terminal end of the artery of one fetus does not have a corresponding returning vein to the same fetus. The portion of the placenta where the vascular territory of the donor twin meets that of the recipient twin is referred to as the vascular equator ( Fig. 1) . 7 Under constant sonographic monitoring, coagulation is applied to all such communications along this equator via repeated laser bursts, resulting in the complete separation of both fetal circulations while maintaining normal perfusion to cotyledons of each individual fetus. 1, 4, 6 This method of selectively choosing which vessels to apply the photocoagulation is referred to as selective laser photocoagulation of communicating vessels (SLPCV). 6, 9 The process has undergone improvements through the study of the placentas following delivery as part of the Eurofoetus study. Once laser photocoagulation has been administered, a portion of the amniotic fluid from the recipient's sac is removed to decrease the maternal risk of premature labor and preterm rupture of membranes, as well as to minimize maternal discomfort associated with polyhydramnios.
RISKS AND BENEFITS
As with any surgical procedure, certain risks are inherent. The risks associated with laser photocoagulation therapy include infection of the amniotic cavity or chorioamnionitis, bleeding, trauma, leakage of fluid, miscarriage, and fetal death. Occurrences of these potential risks are minimized by the small diameter of the fetoscope (2-4 mm), sonographic monitoring throughout the procedure, prophylactic antibiotics, and the administration of tocolytic agents and analgesics during the procedure in some cases. 4 In the case of severe TTTS, the risk of fetal loss with no treatment is greater than 90%. Thus, risks associated with the procedure are minimal in comparison when the benefits include an 80% survival rate of at least one twin, a 50% rate for both twins, and a less than 5% incidence of cerebral palsy. 1,9 Such success rates have led to the performance of this technique in both Europe and the United States, where studies are ongoing in a limited number of specialized facilities.
The Role of Sonography
The role of sonography has been invaluable in the overall evaluation of severe TTTS. Not only is sonography the primary tool in the diagnosis and staging of this condition, but serial sonographic studies are also essential in closely monitoring the progression and ultimate outcome when undergoing laser photocoagulation of communicating vessels. Functional sonographic studies of the fetal circulation (Doppler) have enhanced the understanding of the pathophysiology of TTTS. The staging that sonography allows has provided a common language with which to compare results.
DIAGNOSIS
The initial diagnosis of TTTS is based on the presence of polyhydramnios of > 8 cm MVP (Fig.  2 ) and a large fetus with a prominent bladder in one sac, as well as a smaller fetus with an oligohydramnios of < 2 cm MVP and an empty bladder in the other sac. The smaller or donor twin has the appearance of being "stuck" to the uterine wall. The dividing membrane actually appears to wrap around the donor twin due to the lack of amniotic fluid within the sac. Other criteria for diagnosis have included discordant fetal weight, a single placenta, a thin dividing membrane between the amniotic sacs without the presence of the "twin peak" sign, determination of same-sex fetuses, hydrops, and abnormal Doppler studies. Although fetal weight discordance is expected, it is not a requirement of the diagnosis. Monochorionicity, as defined by a thin or absent membrane, is a requirement of the diagnosis.
Quintero et al. 5 proposed a staging system based on sonographic and Doppler findings. The sequence of progression proceeds as follows (Table 1) According to Allen et al., 1 laser photocoagulation therapy may not be necessary for patients presenting in stage 1, particularly if they are at 26 weeks gestation or beyond. These cases may be managed more effectively and less invasively through close monitoring and serial amniocentesis. Alternatively, patients are considered for surgical intervention when the fetuses' gestational age is between 16 and 26 weeks and meet the criteria for stages 2 through 4. The prognostic significance of a sonographic staging system has allowed the continued development and understanding of treatment options available when counseling pregnant women diagnosed with TTTS.
PREOPERATIVE EVALUATION
Once a patient is considered to have met the necessary criteria for undergoing laser surgery, she un- dergoes a thorough sonographic assessment by the fetal surgeon and sonographer. A complete Doppler study to evaluate the fetal arterial and venous systems is obtained, and placental position and placental umbilical cord insertion points are located. The identification of the placental umbilical insertion allows an approximation of the likely vascular equator of the placenta. 7 The equator must, by necessity, run between the cord insertions and has been observed to often run in a direction parallel to the lie of the "stuck" twin. The identification of this equator, where many of the anastamoses will lie, allows the surgeon to plan the point of entry that will allow optimum views along the line of the equator at an appropriate angle-repositioning of the fetoscope is not possible once an entry into the uterus has been made.
Identification of a placenta-free area in the anterior portion of the uterus is preferred. Quintero et al. 7 discussed the techniques used in cases with the more challenging anterior placentas. A less than desirable insertion point can complicate the surgical assessment of the vascular communications within the placenta. Occasionally, the condition of severe polyhydramnios can actually conceal the placental edge as seen on a sonogram. When necessary, a lateral placenta-free approach is preferable to a fundal approach to allow a greater range of motion to maneuver the endoscope. Maternal vessels can complicate a lateral entry but can be identified using color Doppler prior to entry. The inferior portion of the uterus, which is more prone to membrane detachment and leakage, should be avoided. Positioning of the stuck twin between the insertion point and the area of the vascular equator should also be avoided. Regardless of the challenges involved with insertion point selection, Quintero et al. 7 were unsuccessful in finding placenta-free insertion points in only 2 out of 240 procedures in a seven-year period.
INTRAOPERATIVE EVALUATION
Sonographic evaluation during the intraoperative stage of the laser photocoagulation procedure begins with an additional sonogram immediately prior to the procedure to obtain a reliable fetal heart rate (FHR). As this is an aseptic procedure, the sonographer then scrubs and is gowned and gloved. Aseptic technique is maintained with the hand that is holding the transducer in the surgical field while the nonsterile hand operates the sonographic equipment. Intraoperatively, sonographic visualization of the placenta, amniotic cavity, and the fetus allows safe guidance for the insertion of the endoscope into the sac of the recipient twin (Fig. 6 ). The sonographer is responsible for continuous assessment of the fetuses, the placenta, and the amniotic cavity. Fetal heart rates are checked and documented frequently during the operative period. Fetal bradycardia (defined as a heart rate of less than 120 beats per minute 1 ) occurs occasionally and generally resolves quickly. Upon completion of the laser photocoagulation treatment, the sonographer assists the surgeon in removing excess amniotic fluid (Fig. 7) . Once the Hydrops is present in either twin. 5
Fetal demise of one or both twins.
MVP measures approximately 5 cm, the procedure is complete and the instrument is removed. Immediately after the procedure, the sonographer again assesses and documents the FHR of both fetuses and evaluates the fetoscopic entry point for evidence of intra-amniotic bleeding.
POSTOPERATIVE EVALUATION
Postoperative sonographic evaluation occurs one day after the surgical procedure. Maternal complications, such as intraperitoneal bleeding or leakage of amniotic fluid into the peritoneal cavity, can be detected at this time. In addition, the perinatologist and sonographer thoroughly reassess the fetuses by sonography. Coagulation of the communicating vessels has a profound hemodynamic effect on the clinical development of the fetuses. Some of these changes can be observed easily by sonography. Features suggestive of successful division of fetal circulation include the normalization of amniotic fluid volumes and fetal bladder sizes. Absence of these signs, on the other hand, is more suggestive of failed therapy.
Weekly follow-up is recommended for one month following the procedure. Resolution of the transfusion process following laser surgery has been defined as successful if fluid did not reaccumulate in the recipient's sac, if fluid did increase in the donor's sac, if normalization of bladder sizes had occurred by 2 weeks following the treatment, and if neonatal survival and sonographic brain scans at 28 weeks were normal. Ninety percent of the time, these criteria were met in a study by Gratacos et al. 2 Recently, several studies have been aimed at the impact of treatment of TTTS with laser photocoagulation of the communicating vessels on changes in fetal Doppler indices, venous blood flow volume, hydrops, tricuspid regurgitation, and the prognostic value of these signs.
The study by Gratacos et al. 2 investigated the incidence and relevance of hydropic signs in the donor fetus following laser surgery. In the recipient, new-onset hydrops is interpreted as being related to congestive heart failure and is thus a poor prognostic sign following laser surgery. The same condition in the donor, however, seems to be a more transient state and is not necessarily of poor prognostic value. In most cases, these signs developed by days 1 to 3 and disappeared a few days later. Research has shown that 25% of donor fetuses developed some hydropic signs following the laser procedure. 2, 3, 8 Investigators have observed similar changes, along with the absence or reversal of blood flow, as well as significant increases in the pulsatility index (PI) of the ductus venosus. 8 Previous studies suggested that such hemodynamic changes are due to increased placental resistance and fetal hypertension due to unequal placental sharing. 4 Zikulnig et al. 8 maintain that placental insufficiency remains a contributor to donor mortality, particularly in those cases in which there is a greater difference in the size between fetuses. In the same study, however, it is emphasized that an increase in ductus venosus pulsatility one day after the procedure does not correlate with a decrease in the survival rate of the donor. Instead, it seems to be a transient sign of circulatory adaptation to the separation of communicating vessels. This was confirmed by Gratacos et al., 3 after a prolonged follow-up with serial sonography, performed at one, three, and five days following laser treatment, showed the PI slowly returning to preoperative levels or below. In the same study, it was determined that not only did the Doppler indices of the donor return to preoperative values by day 5 following surgery, but the umbilical vein flow volume also increased by 50% the day after treatment and remained elevated. Finally, although a few donors were found to have developed tricuspid regurgitation following the laser surgery, this seemed to disappear during the five days following the procedure. 3 Gratacos et al. 3 observed significant reversal of disturbances within the recipient as well as the donor. In the five days following the laser surgery, the recipient showed a progressive decrease in the ductus venosus PI, which corresponds to improvement in previously noted signs of right heart failure. In addition, tricuspid regurgitation had disappeared in 45% of those recipients in whom the condition was present before laser surgery. 3
Alternative Treatment
Prior to the recent success in laser photocoagulation therapy, the alternative method of treating TTTS has involved serial amnioreduction, which has been found useful in decreasing the intra-amniotic pressure, thus decreasing the risks of miscarriage or preterm labor associated with the condition of polyhydramnios. In contrast to laser therapy, this method has had variable success through treating the effects of the syndrome rather than the cause. The incidence of neurological complications associated with serial amniocentesis is reportedly approximately 25%. 1, 9 In less severe cases of TTTS, in which the bladder of the donor twin is still visible (stage 1), amnioreduction has been found to be an effective management technique, provided that the syndrome does not progress to the more severe stages. 5 Comparison studies involving patients with severe TTTS have reported that although the overall survival rate was only slightly higher in the lasertreated group, there was a higher percentage of pregnancies with at least one survivor in 66% to 83% of the cases. 9 In addition, there was a lower number of spontaneous intrauterine deaths of both fetuses, a lower incidence of brain abnormalities found on postnatal sonograms, and a more advanced gestational age at delivery, resulting in a higher birth weight in those treated by laser therapy. 4, 8, 9 The subject of which method is the optimal treatment for patients with TTTS has been an area of ongoing controversy. Although amniocentesis is more readily available, requires less training, and is less costly, recent data have shown that the two methods do not yield the same results. Recent research by Quintero et al. 9 showed an inverse relationship between the stage of TTTS and the likelihood of a successful pregnancy outcome in the amnioreduction group but not in the SLPCV group. This suggests the superiority of laser therapy over amnioreduction. Even so, a randomized clinical trial of amnioreduction versus laser therapy by the Eurofoetus group is ongoing in Europe to gain a better understanding of the advantages and limitations of each method. 9
Conclusion
Sonographic evaluation has been a key component in the recent evolution of the treatment of TTTS by laser photocoagulation of communicating vessels. Through the use of sonography from initial diagnosis of the syndrome, through followup, to postnatal neurological evaluation, the prognosis at individual stages of the syndrome becomes better understood. Over the past decade, research has shown that survival rates of those affected by TTTS have improved following SLPCV. Although studies are ongoing, this early success now gives hope to parents who, up to this point, had no curative options with which to deal with the syndrome.
